Endocrine System Diseases  >>  pamrevlumab (FG-3019)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pamrevlumab (FG-3019) / FibroGen
NCT02851381: Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic Cancer

Withdrawn
N/A
0
US
FG-3019
Jonsson Comprehensive Cancer Center
Pancreatic Cancer
09/16
08/17

Download Options